B Braun receives CE Mark for Coroflex ISAR stent

B Braun has announced that its next-generation medical device, the Coroflex ISAR stent, has received European CE Mark approval.

The device was developed in cooperation with the German Heart Centre and is intended for the treatment of stenoses in coronary arteries. A cutting-edge sirolimus-eluting stent, the device offers a number of benefits in terms of flexibility and long-term patient safety.

Its proprietary polymer-free matrix coating combines high efficacy in the prevention of restenosis with a fast healing process when implanted in the artery. This has been demonstrated by results from the ISAR-TEST 5 trial, which shows there are no definitive late thrombotic events associated with this matrix coating.

The stent is the latest product offering from B Braun's vascular systems business in Berlin to offer positive benefits in the field of polymer-free angioplasty.

Its launch comes as the company is celebrating its 175th anniversary, which is taking place throughout this year, giving B Braun an opportunity to showcase the many contributions it has made to the development of medicine since 1839.